Select Neurotech & AI Portfolio
Where Visionary Science Meets Venture Excellence
Kaleida Capital’s portfolio represents the future's most promising neurotech and AI companies, carefully selected through our rigorous scientific diligence and strategic vision. Each investment demonstrates our commitment to backing exceptional founders building breakthrough technologies in neural engineering and artificial intelligence.
-
Manifest Technologies
(ACQUIRED 2024) A computational neuroimaging platform improving drug development for patients with schizophrenia and bipolar disorders.
-
Paradromics
A breakthrough brain-computer interface technology restoring speech and motor function in patients with paralysis, ALS, and spinal cord injuries.
-
Anthropic
A leading generative AI research company, recently securing a major investment from Amazon and positioned as a major force alongside OpenAI.